[go: up one dir, main page]

GB0611565D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0611565D0
GB0611565D0 GB0611565A GB0611565A GB0611565D0 GB 0611565 D0 GB0611565 D0 GB 0611565D0 GB 0611565 A GB0611565 A GB 0611565A GB 0611565 A GB0611565 A GB 0611565A GB 0611565 D0 GB0611565 D0 GB 0611565D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0611565A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sentinel Oncology Ltd
Original Assignee
Sentinel Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinel Oncology Ltd filed Critical Sentinel Oncology Ltd
Priority to GB0611565A priority Critical patent/GB0611565D0/en
Publication of GB0611565D0 publication Critical patent/GB0611565D0/en
Priority to EP07733133A priority patent/EP2038257A1/en
Priority to JP2009514881A priority patent/JP2009539956A/en
Priority to US12/304,345 priority patent/US20090270416A1/en
Priority to PCT/GB2007/002123 priority patent/WO2007144579A1/en
Ceased legal-status Critical Current

Links

GB0611565A 2006-06-12 2006-06-12 Pharmaceutical compounds Ceased GB0611565D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0611565A GB0611565D0 (en) 2006-06-12 2006-06-12 Pharmaceutical compounds
EP07733133A EP2038257A1 (en) 2006-06-12 2007-06-08 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer
JP2009514881A JP2009539956A (en) 2006-06-12 2007-06-08 Medicine
US12/304,345 US20090270416A1 (en) 2006-06-12 2007-06-08 N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER
PCT/GB2007/002123 WO2007144579A1 (en) 2006-06-12 2007-06-08 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0611565A GB0611565D0 (en) 2006-06-12 2006-06-12 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0611565D0 true GB0611565D0 (en) 2006-07-19

Family

ID=36745707

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0611565A Ceased GB0611565D0 (en) 2006-06-12 2006-06-12 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB0611565D0 (en)

Similar Documents

Publication Publication Date Title
ZA200809546B (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
GB0721095D0 (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
GB0707087D0 (en) Pharmaceutical compounds
GB0704932D0 (en) Pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608397D0 (en) Pharmaceutical compounds
GB0608178D0 (en) Pharmaceutical compounds
GB0625431D0 (en) Pharmaceutical compounds
GB0615299D0 (en) Pharmaceutical compounds
GB0615293D0 (en) Pharmaceutical compounds
GB0614456D0 (en) Pharmaceutical compounds
GB0613520D0 (en) Pharmaceutical compounds
GB0611565D0 (en) Pharmaceutical compounds
GB0625668D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)